Ø RBI doubles foreign investors’ sub-limit in govt bonds to $10bn
Ø FDI flows into India up 17 % to $ 28 b in 2013: UN report
Ø Eight telcos to bid in spectrum auction next week
Ø Liberal policies makes India top investment destination: Govt
Ø Ranbaxy’s plant under Indian regulator’s watch too
Ø Gas prices may rise over $9 as US rates hit 4-yr high
Ø India Ratings maintains stable outlook for oil & gas sector
Ø ICICI Bank Q3 net up 13% at Rs 2,532 cr
Ø Suzuki takes away production and transparency from Maruti
Ø Bharti Airtel Q3 net more than doubles, at Rs 610 crore
Ø Taper fears and F&O expiry halts market in its track
Ø New exit policy for road developers notified
Ø Time to capitalise on better CAD, says RBI
Ø MCX withdraws Mild Steel contracts from trading
Ø FDI in food processing shoots up to $2.14 billion in April-Oct 2013
Ø GAIL (India) net profit jumps 31% in Dec quarter
Ø Japan’s Dentsu bets big on India, other foreign markets
Ø Lupin recalls Quinapril tablets from US market
Ø Q3 booster for Crompton Greaves
Ø Raghuram Rajan says rate hike not in light of global contagion
Ø GVK Bio acquires US-based Aragen Bioscience
Ø TVS Motor Q3 net profit rises 31% to Rs.68.8 crore
Ø Godrej Properties posts muted profit as sales weaken
Ø Shell cuts stake in Brazil oil project with $1 bn sale to Qatar
Ø India ranked at the bottom of Intellectual Property Index
Ø Polaris Financial Q3 Net up 24.8 per cent to Rs 50.75 cr
Ø Now, EU and UK regulators evaluating FDA findings on Ranbaxy’s Toansa facility
Ø Appetite for M&A deals improving in India, globally: KPMG
Ø Merck and Bristol settle lawsuit with Aurobindo
Ø NTPC places 7 stressed power projects on acquisition radar
Ø Trai seeks to lock-in traded spectrum
Ø Moily seeks flexibility to ease RIL, Cairn timelines
Ø US FDA seeks to ban trans fats in processed foods due to health risks
